Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.52B | $6.13B | +6.37% |
Operating Income | $4.23B | $3.93B | +7.58% |
Net Income | $4.07B | $3.53B | +15.50% |
EPS (Basic) | $11.18 | $9.69 | +15.38% |
EPS (Diluted) | $11.16 | $9.67 | +15.41% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $198.42B | $137.45B | +44.36% |
Current Assets | $165.36B | $103.03B | +60.49% |
Total Liabilities | $169.7B | $110.96B | +52.93% |
Current Liabilities | $160.3B | $102.31B | +56.67% |
Stockholders' Equity | $28.73B | $26.49B | +8.46% |
Cash & Equivalents | $4.42B | $2.89B | +52.71% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $4.28B | $3.69B | +15.89% |
Investing Cash Flow | $1.5B | $-82.6M | +1914.53% |
Financing Cash Flow | $56.51B | $5.08B | +1013.16% |
Dividends Paid | $3.93B | $3.58B | +9.73% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 64.9% | 64.1% | +0.73% |
Net Margin | 62.5% | — | — |
ROE | 14.2% | — | — |
ROA | 2.1% | — | — |
Current Ratio | $1.032 | — | — |
Debt to Equity | $5.907 | — | — |
CME's 2025 fiscal year results show strong revenue and net income growth, driven by increased operating efficiency and asset expansion.
CME achieved a 6.4% increase in revenue, driven by higher trading volumes and new product offerings.
Source: Source: 10-K Item 7, p.45
Operating income rose by 7.6%, reflecting improved cost management and operational efficiencies.
Source: Source: 10-K Item 7, p.46
Total assets increased by 44.4%, primarily due to strategic acquisitions and investment in technology infrastructure.
Source: Source: 10-K Item 7, p.47
CME's performance is highly sensitive to market volatility, which can impact trading volumes and revenue.
Source: Source: 10-K Item 1A, p.12
Unlock 2 more detailed risk analysis